Since HMG-CoA reductase is upregulated in gastric cancer, promoting tumor growth and migration [20], the blockade of HMG-CoA reductase by statins has been considered to be the key mechanism involved in the chemoprevention of statins in gastric cancer [20]. This evidence concerns the gene HMGCR and neoplasm.